Inactive Instrument
Abpro Corporation Share Price Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 1.16M 1.01M 935K 875K 1.64M 109M 1.65M 11.09M 4.3M 53.79M 4.35M 4.25M 187M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.24M 1.08M 1M 936K 1.76M 117M 1.77M 11.86M 4.6M 57.51M 4.65M 4.55M 200M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.16M | |
| +1.44% | +1.71% | -10.63% | -9.16% | 43.13B | |
| +3.31% | +5.93% | +308.19% | +562.02% | 34.65B | |
| +2.84% | +2.14% | +6.87% | +34.93% | 30.03B | |
| -1.70% | -7.54% | +8.51% | -22.34% | 28B | |
| -1.90% | -1.56% | +11.62% | +19.80% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +52.04% | +107.47% | 13.14B | |
| -0.57% | -2.43% | +5.18% | +4.20% | 12.53B | |
| -0.26% | +1.15% | +100.27% | +80.69% | 12.25B | |
| Average | +0.37% | +0.73% | +60.26% | +97.20% | 23.61B | |
| Weighted average by Cap. | +0.77% | +1.27% | +65.22% | +113.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 160K 148K 138K 259K 17.27M 261K 1.75M 679K 8.5M 687K 672K 29.51M | - |
| Net income | -7.23M -6.31M -5.84M -5.47M -10.25M -682M -10.32M -69.28M -26.85M -336M -27.15M -26.56M -1.17B | -2.89M -2.52M -2.34M -2.19M -4.1M -273M -4.12M -27.7M -10.74M -134M -10.86M -10.62M -466M |
| Net Debt | 478K 417K 386K 361K 678K 45.1M 682K 4.58M 1.77M 22.2M 1.79M 1.76M 77.09M | 80K 69.75K 64.6K 60.48K 113K 7.55M 114K 766K 297K 3.72M 300K 294K 12.9M |
Employees
-
